Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02999438 · ClinicalTrials.gov registry record

Frailty in Children With Cardiac Disease

A clinical trial of Heart Failure and Pulmonary Hypertension, sponsored by Children's Mercy Hospital Kansas City.

Completed
Registry status
56
Enrollment target
1
Study location

NCT02999438 is a study of Heart Failure and Pulmonary Hypertension that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 56 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02999438, a study of Heart Failure and Pulmonary Hypertension, has completed, sponsored by Children's Mercy Hospital Kansas City.

COMPLETED
Registry status
56 participants
Enrollment target
1
Study location

Study Summary

Frailty is a complex biologic syndrome of diminished physiologic reserve that leads to decreased resistance to stressors and is associated with adverse health outcomes. The syndrome has been well studied in adults and is quantified by the Fried criteria, which are comprised of five components- slowness, weakness, self-reported exhaustion, shrinkage and diminished physical activity. The concept of frailty is novel in children. A study in young adult childhood cancer survivors demonstrated increased incidence of frailty in this population along with increased risk of morbidity and mortality. This suggests that frailty as a phenotype has relevance outside of the geriatric age group. Pediatric patients with single ventricle physiology, heart failure and pulmonary artery hypertension- all represent populations with significantly increased risk of mortality, morbidity and decreased quality of life. Currently, such patients are monitored outpatient by serial echocardiograms and blood work that only gives information about end organ damage. But there is no validated tool available to measure global infirmity in such children. Better understanding of the relevance and applicability of frailty in pediatrics may allow for identification of the most vulnerable pediatric cardiac patients and be of value in optimizing their clinical management and improving health outcomes.

Interventions

  • DEVICE Actigraph to check activity levels at home

Study Locations (1)

Missouri

  • Children's Mercy Hospital - Kansas City

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2016-11
Est. Completion 2022-10

What the Registry Record Tells You About NCT02999438

The ClinicalTrials.gov registry entry for NCT02999438 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Actigraph to check activity levels at home is the first listed.

NCT02999438 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT02999438 about?

NCT02999438 is a clinical study titled "Frailty in Children With Cardiac Disease". Frailty is a complex biologic syndrome of diminished physiologic reserve that leads to decreased resistance to stressors and is associated with adverse health outcomes. The syndrome has been well studied in adults and is quantified by the Fried criteria, which are comprised of five components- slown...

What is the current status of trial NCT02999438?

This trial is currently completed. The enrollment target is 56 participants. The study started on 2016-11. Estimated completion is 2022-10.

What conditions does trial NCT02999438 study?

This clinical trial studies the following conditions: Heart Failure, Pulmonary Hypertension, Single-ventricle.

What interventions are being tested in trial NCT02999438?

The interventions under investigation include: Actigraph to check activity levels at home (DEVICE).

Who is sponsoring clinical trial NCT02999438?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02999438 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.